Prostaganin a new anti prostate cancer drug
Friday, September 11th, 2009 Posted in prostate cancer | No Comments »GENova Biotherapeutics, Inc., announce that it has filed a patent for a novel peptide, called Prostaganin, that disrupts the advance of prostate cancer and thus has blockbuster potential as a new anti-cancer drug. The peptide, is a 21-amino compound which is ...
Hormone therapy not suitable for every cancer patient
Wednesday, September 9th, 2009 Posted in hormone therapy, radiation therapy | No Comments »A new study in the Journal of the American Medical Association (JAMA) appears to support the theory outlined in earlier studies that men with more advanced forms of prostate cancer don't benefit from a combination of hormone and radiation therapy. ...
A simple jab may soon help avoid prostate cancer
Tuesday, September 8th, 2009 Posted in prostate cancer prevention | No Comments »The research team from University of Utah and University of Columbia have identified a virus, known to trigger leukaemia, in malignant human prostate cancer cells. The viral proteins were found almost exclusively in malignant prostatic cells, suggesting that XMRV (Xenotropic ...
Scans may detect recurring prostate cancer
Monday, September 7th, 2009 Posted in prostate cancer diagnosis | No Comments »Italian researchers of the University of Bologna suggest using positron emission tomography and computer tomography with choline to detect recurring prostate cancer earlier. According to lead author Dr. Paolo Castellucci, in most patients with biochemical relapse after radical prostatectomy -- prostate ...
For many men diagnosed with prostate cancer treatment is not necessary
Sunday, September 6th, 2009 Posted in prostate cancer | No Comments »When it comes to treating prostate cancer, doctors should think that it is one of the most slow-growing cancers, so some early cancers don't need to be treated in certain patient populations. This is according the new research that concludes since ...
Prostate patients who avoid prostatectomy ‘can live for years’
Saturday, September 5th, 2009 Posted in prostate cancer diagnosis, prostatectomy, watchful waiting | No Comments »British scientists have concluded that many men with prostate cancer who decide not to go for surgery or other invasive therapies such as radiotherapy fare just as well as those who do choose the treatment. According to opinion of research team, ...
Do patients on watchful waiting experience anxiety and distress?
Friday, September 4th, 2009 Posted in watchful waiting | No Comments »Specialists say that when doctors recommend watchful waiting (active surveillance) and other forms of “non-interventional” management for prostate cancer, patients suffer unduly from anxiety and distress while living with “untreated” cancer. There are some patients who find the idea of ...
IGRT suggested as improved treatment for obese prostate cancer patients
Thursday, September 3rd, 2009 Posted in radiation therapy | No Comments »Moderately to severely obese prostate cancer patients may have improved treatment outcomes when treated with image-guided radiation therapy (IGRT) over traditional external beam radiation therapy (EBRT) because IGRT corrects for prostate shifts, which, if not planned for, can lead to ...
Adult weight gain linked to prostate cancer risk
Wednesday, September 2nd, 2009 Posted in prostate cancer risks | No Comments »Obesity is a risk factor for many common cancers, but is still unclear whether it plays a role in prostate cancer risk. A research team from the University of Hawaii reports men who pack on excess pounds as young adults ...
Prostate cancer over diagnosed
Tuesday, September 1st, 2009 Posted in prostate cancer diagnosis | No Comments »A new study at the Dartmouth Medical School's Institute for Health Policy and Clinical Practice concludes mass screening for prostate cancer with a test for prostate-specific antigen (PSA) has led to mass over-diagnosis and over-treatment. The study also reports in the ...